Ravi Misra
Stock Analyst at Truist Financial
(0.52)
# 4,013
Out of 4,429 analysts
38
Total ratings
35%
Success rate
-10.7%
Average return
Main Sectors:
Stocks Rated by Ravi Misra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORGO Organogenesis Holdings | Initiated Coverage: Hold | $3 | $2.44 | +22.95% | 1 | May 28, 2026 | |
| TFX Teleflex | Reiterated: Hold | $143 | $127.00 | +12.60% | 1 | May 11, 2026 | |
| IART Integra LifeSciences Holdings | Maintained: Hold | $14 | $17.58 | -20.36% | 1 | May 6, 2026 | |
| KIDS OrthoPediatrics | Reiterated: Hold | $17 | $18.87 | -9.91% | 1 | May 1, 2026 | |
| ALGN Align Technology | Rated: Hold | n/a | $182.08 | n/a | 4 | Dec 13, 2021 | |
| DXCM DexCom | Rated: Hold | n/a | $72.47 | n/a | 2 | Dec 13, 2021 | |
| PODD Insulet | Rated: Hold | n/a | $145.76 | n/a | 3 | Dec 13, 2021 | |
| TNDM Tandem Diabetes Care | Rated: Hold | n/a | $15.30 | n/a | 2 | Dec 13, 2021 | |
| AVNS Avanos Medical | Rated: Hold | n/a | $24.94 | n/a | 2 | Dec 13, 2021 | |
| GKOS Glaukos | Rated: Hold | n/a | $130.68 | n/a | 2 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.07 | n/a | 7 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $42.61 | n/a | 5 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.67 | n/a | 2 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.43 | n/a | 4 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $283 | $406.78 | n/a | 1 | Apr 19, 2017 |
Organogenesis Holdings
May 28, 2026
Initiated Coverage: Hold
Price Target: $3
Current: $2.44
Upside: +22.95%
Teleflex
May 11, 2026
Reiterated: Hold
Price Target: $143
Current: $127.00
Upside: +12.60%
Integra LifeSciences Holdings
May 6, 2026
Maintained: Hold
Price Target: $14
Current: $17.58
Upside: -20.36%
OrthoPediatrics
May 1, 2026
Reiterated: Hold
Price Target: $17
Current: $18.87
Upside: -9.91%
Align Technology
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $182.08
Upside: n/a
DexCom
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $72.47
Upside: n/a
Insulet
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $145.76
Upside: n/a
Tandem Diabetes Care
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $15.30
Upside: n/a
Avanos Medical
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $24.94
Upside: n/a
Glaukos
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $130.68
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $8.07
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $42.61
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $1.67
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $8.43
Upside: n/a
Apr 19, 2017
Reiterated: Buy
Price Target: $283
Current: $406.78
Upside: n/a